Garofalo Health Care SpAMIL:GHC +0.77%86 EBITDA Margin % is 16.92% as of Mar. 2026, which is 9% above its 10-year median of 15.53. GuruFocus rates MIL:GHC with a GF Score™ of 86/100 and a GF Value™ of €6.06 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 668 Healthcare Providers & Services companies, Garofalo Health Care SpA ranks better than 60.63% on this metric.
Garofalo Health Care SpA (MIL:GHC) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Garofalo Health Care SpA EBITDA Margin % Related Terms
Garofalo Health Care SpA EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MIL:GHC vs HCA, THC, DVA: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, Garofalo Health Care SpA's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Garofalo Health Care SpA EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Garofalo Health Care SpA's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Garofalo Health Care SpA's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Garofalo Health Care SpA (MIL:GHC) has a EBITDA Margin % of 16.92% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Garofalo Health Care SpA and its competitors. This is near median its historical median of 15.53. Over the past decade, Garofalo Health Care SpA's EBITDA Margin % has ranged from 12.27 to 17.37. According to the industry distribution chart, Garofalo Health Care SpA ranks #263 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 39.4%.
Is Garofalo Health Care SpA's EBITDA Margin % too high?
Garofalo Health Care SpA's current EBITDA Margin % of 16.92% is near median its 10-year median of 15.53. Over the past 10 years, this metric has ranged from a low of 12.27 to a high of 17.37. The Healthcare Providers & Services industry median EBITDA Margin % is 10.21. Garofalo Health Care SpA's value of 16.92% is 65.7% above this industry median. Based on the distribution chart, Garofalo Health Care SpA ranks #263 out of 668 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Garofalo Health Care SpA has a GF Score™ of 86/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Garofalo Health Care SpA's EBITDA Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Garofalo Health Care SpA ranks #263 out of 668 companies for EBITDA Margin %. This puts Garofalo Health Care SpA in the upper half of its industry. The industry median EBITDA Margin % is 10.21. Garofalo Health Care SpA's value of 16.92% is 65.7% above this benchmark. Historically, Garofalo Health Care SpA's own EBITDA Margin % has ranged from 12.27 to 17.37 over the past decade. While the company's 10-year median is 15.53 vs. the industry median of 10.21, Garofalo Health Care SpA has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Garofalo Health Care SpA's current EBITDA Margin % of 16.92% is 65.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Garofalo Health Care SpA and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Garofalo Health Care SpA's current EBITDA Margin % is 16.92%, which is near median its own 10-year median of 15.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Garofalo Health Care SpA stock overvalued right now?
Based on GuruFocus' analysis, Garofalo Health Care SpA (MIL:GHC) is currently considered Modestly Undervalued. The stock's GF Value™ is €6.06, compared to a current price of €5.26 — trading 13.2% below its estimated fair value. The current EBITDA Margin % is 16.92%, which is near median its 10-year median of 15.53 and 65.7% above the Healthcare Providers & Services industry median of 10.21. Garofalo Health Care SpA's overall GF Score™ is 86/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Garofalo Health Care SpA (MIL:GHC), the current EBITDA Margin % is 16.92% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Garofalo Health Care SpA (MIL:GHC) Overvalued in 2026?
Based on GuruFocus' analysis, Garofalo Health Care SpA stock appears to be undervalued.
The current stock price of €5.26 is trading 13.2% below its estimated GF Value™ of €6.06.
GuruFocus considers Garofalo Health Care SpA to be Modestly Undervalued.
Key valuation signals for MIL:GHC:
EBITDA Margin %: 16.92% (near median its 10-year median of 15.53)
GF Value™: €6.06 vs. price of €5.26 (13.2% below fair value)
Industry Position: 65.7% above the Healthcare Providers & Services median (#263 of 668)
No single metric tells the full story. See the MIL:GHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Garofalo Health Care SpA is an Italian accredited private healthcare provider offering a comprehensive range of services across various areas of healthcare through diversified specialties, supported by the use of technologies and qualified personnel. The Group mainly operates in regions of northern and central Italy, which have been selected based on their attractiveness in terms of per capita healthcare spending, above-average per capita income, and well-developed internal transport infrastructure.
86GF Score
Get the complete analysis for MIL:GHC
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MIL:GHC has been successfully added to your 
